Ambulatory Care

Residency Program Director
  • Melissa Snider, PharmD, BCACP, CLS

    • Manager and Specialty Practice Pharmacist, Ambulatory Care
    • Clinical Assistant Professor, The OSU College of Pharmacy
    • PGY2 Ambulatory Care Residency Program Director
    • PharmD- Ohio Northern Univeristy
    • PGY1 Veterans Affairs Medical Center

    Related Research

Previous Year Residents
  • Ashley Lopez, PharmD

    Ambulatory Care Specialty Pharmacist - The Ohio State University Wexner Medical Center
  • Bethany Anderson, PharmD

    Heart Failure/Anticoagulation Clinical Pharmacy Specialist - Cleveland Clinic Main Campus
  • Brilliana Hou, PharmD

    Neurology Pharmacist, MultiCare, Tacoma, Washington
  • Sarah Hasan, PharmD, MBA

    Ambulatory Care Specialist, The Ohio State University Wexner Medical Center
  • Victoria DaSilva, PharmD

    Ambulatory Care Specialist, The Ohio State University Wexner Medical Center
  • Alyssa Rinaldi

    Ambulatory Care Specialty Practice Pharmacist, The Ohio State University Wexner Medical Center
  • Nicole Thomas

    Clinical Pharmacy Specialist, Ambulatory Care, University of Cincinnati
  • Allyson Helms

    Clinical Pharmacist Specialist, Complete Endocrinology Clinic/Cardiometabolic Center/Primary Care Clinics, Bryan Health, Lincoln, NE
  • Katharine Lundy

    Clinical Pharmacist, Franciscan Health, Olympia Fields, IL
  • Caitlin Mills

    Specialty Practice Clinical Pharmacist, The Ohio State University Wexner Medical Center
  • Erika Top

    Clinical Pharmacist, Neurology, Northwell Health
  • Jennifer Lee

  • Tara Nagaraj

    Ambulatory care pharmacist, Saint Elizabeth Healthcare, Kentucky
  • Hannah Rhinehart

    Ambulatory Care Specialty Practice Pharmacist, The Ohio State University Wexner Medical Center
  • Adam Ingram

    Ambulatory Care Specialty Practice Pharmacist, The Ohio State University Wexner Medical Center
  • Megan Borchers

    Ambulatory Care Specialty Practice Pharmacist, St. Elizabeth Healthcare in Northern Kentucky
  • Elisa Baddour

    Primary Care Clinical Specialist position at the Cleveland Clinic
  • Lindsey Meston

    Clinical Pharmacist, Chronic Care Management and Transitions of Care Services, Asti's Pharmacy, Pittsburgh
  • Marie Waddles

    Ambulatory Care Clinical Pharmacy Specialist, WakeMed Hospital, Raleigh, North Carolina, & Assistant Professor of Clinical Pharmacy, UNC Eshelman School of Pharmacy
  • Erica Davidson

    Ambulatory Care Specialty Practice Pharmacist, The Ohio State University Wexner Medical Center
  • Abby Rabatin

    Ambulatory Care Specialty Practice Pharmacist at The Ohio State University Wexner Medical Center
  • Elise Albro

    Ambulatory Care Specialty Practice Pharmacist at The Ohio State University Wexner Medical Center
  • Cecelia Jebbia, PharmD

    Ambulatory Care Specialty Pharmacist - The Ohio State University Wexner Medical Center

About the PGY2 Ambulatory Care – Wexner Medical Center Residency Program


PGY2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

PGY2 at Wexner Medical Center residency graduates are primed for ambulatory practice as an independent clinical specialist within pharmacy-run clinics, and for ambulatory leadership, teaching, and research.  Not only will the residents develop the ability to treat and appropriately triage the most complex chronic and acute illnesses presented by ambulatory patients, but also will have the ability to manage operational aspects of ambulatory care, to expand/develop innovative programs or services that contribute to the public’s health, and to participate in professional organizations.

Read More

In addition, the leadership, research, and presentation skills of graduates equips them to serve the ambulatory practice as experts on development and expansion of services, participating in and completing research and quality improvement projects, delivering medication management therapy, and sustainability of pharmacy services to outpatients.  The residents will also demonstrate an advanced capability to provide insightful education or training for students, pharmacy residents, pharmacy colleagues, nurses, and physicians.

Residency Sites

The PGY2 Ambulatory Care resident will practice within the OSUWMC Health-System, including hospital based clinics within the Richard M. Ross Heart Hospital, a leader in cardiovascular care, as well as several non-hospital based clinics within OSU Outpatient Care centers. The pharmacist-driven ambulatory care clinics operate under collaborative practice agreements. Ambulatory Care Specialty Pharmacists are privileged by the institution and involved in many areas of patient care including anticoagulation management, cardiovascular risk reduction, medication therapy management, hep C medications, and smoking cessation services.

The PGY2 Ambulatory Care Residency at The Ohio State University Wexner Medical Center combines clinical, administrative, and project management experiences in various specialized areas. The residency provides a well-rounded experience to help develop the resident’s clinical and operational expertise. The resident becomes a core member of the Ambulatory Care Pharmacy team through structured rotation experiences and projects. The resident will be encouraged to seek opportunities in their areas of interest.

Read about the sites

As one of America’s top ranked academic medical centers, the mission of The Ohio State University Wexner Medical Center (OSUWMC) is to improve people’s lives through innovation in research, education, and patient care. OSUWMC is a 1,506 bed multihospital delivery system recognized in 2018 as one of “America’s Best Hospitals” for excellence in ten specialties by US News and World Report based on quality, outcomes, and reputation.

University Hospital (UH)

University Hospital (UH) is our flagship hospital with over 900 beds. UH is a major referral center for patients throughout Ohio and the Midwest, and is one of the busiest kidney and pancreas transplant centers in the world. UH is also an international center for neuromodulation research and neurological care. In addition, UH is a level 1 trauma center in addition to being the primary burn center for the region. The James Cancer Hospital and Solove Research Institute is one of the nation’s premier centers for the prevention, detection and treatment of cancer.

OSUWMC features the world’s most advanced cancer and critical care hospital which opened in December of 2014. With the opening of the new hospital, our institution boasts an Emergency Department (ED) with over 100 beds and an area dedicated specifically to the care of cancer patients within the ED. Medical Intensive Care, Surgical Intensive Care, Neuro Intensive Care, and Cancer specific ICU patient care areas also exist within the new critical care tower.

The Ross Heart Hospital

The Ross Heart Hospital is a leader in cardiology and heart surgery and is the only nationally ranked heart hospital in the area. Each floor of the 150-bed hospital is dedicated to a specific service, which helps us provide specialized care for every patient. The Ross is one of the largest centers for the implantation of LVAD devices in the world in addition to providing heart and lung transplants.

The James Cancer Hospital 

The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Solove Research Institute (OSUCCC–James) is the Midwest’s first freestanding cancer hospital and is funded by the National Cancer Institute to conduct both phase I and phase II clinical trials on novel anticancer drugs.  The James is one of the nation’s premier cancer centers for the prevention, detection and treatment of cancer.

University Hospitals East 

University Hospitals East (UHE) blends the friendly atmosphere of a community hospital with the advantages of being a part of a major academic medical center. Located on the eastern edge of downtown Columbus, University Hospital East offers renowned Ohio State services in orthopedic care, emergency services, cancer care, addiction services, ear, nose and throat care, heart care, radiology and imaging services, rehabilitation and wound healing.

OSU Outpatient Care Sites (Dublin, Upper Arlington, New Albany, Gahanna, East)

These sites provide high-quality and conveniently located health services with an emphasis on prevention of disease and illness, as well as the treatment of routine and complex medical conditions across the spectrum of one’s life.

Central Ohio Primary Care (COPC)

COPC is the largest physician-owned primary care medical group in the United States with over 300 providers and 55 practice locations throughout central Ohio.

The Brain and Spine Hospital

The Brain and Spine Hospital opened in the Fall of 2016 and is a state-of-the-art facility for the advanced management, care and healing of patients with neurological disorders.The hospital consists of 87 private beds and specialized units for stroke and neurovascular, neurotrauma, epilipsy, spine, chronic pain, neuromodulaton, multiple sclerosis, congnitive and movement disorders, as well as an innovative new model for acute spinal cord injuries.

The Department of Pharmacy

The Department of Pharmacy at The OSUWMC is one of the largest in the country.  With over 400 employees, and a practice model that includes both clinical pharmacy generalists and clinical pharmacy specialists, our goal is the provision of outstanding, state of the art care. We advise our staff on the best use of medications, develop safeguards for our patients to prevent medication errors and develop transformative pharmacy practice in health-systems.

We are guided in this mission by our strategic plan that focuses on five key priorities: optimizing our pharmacy information system, refining our practice model, enhancing our medication safety program, establishing the pharmacy as a workplace of choice in Central Ohio and refining our academic relationships and department scholarship. Training future generations of pharmacists is a vital part of our mission. Our pharmacists serve as preceptors for our residency programs while providing experiential training for Doctor of Pharmacy (PharmD) students.

Our residency program has a 55-year tradition of excellence with our graduates being well-prepared to work at a high-level in a wide-variety of institutional and ambulatory patient care facilities. The Department of Pharmacy, in partnership with the OSU College of Pharmacy, strives to develop the skills of our residents and provide a residency program that is recognized nationally for the quality and Ohio State University Wexner Medical Center.


Key rotations/experiences

Rotational experiences for the Wexner Medical Center (WMC) PGY2 residency in ambulatory care are designed to provide the resident with an exposure to a variety of ambulatory pharmacy services and patient populations.  One of the most notable features of the PGY2 Ambulatory Care residency at the OSUWMC is the wide variety of rotation options and flexibility in scheduling and customization to individual interests. 

Read More

The resident is required to complete one orientation month.  Within the first three months, the resident is strongly encouraged to complete a one month acute care cardiology rotation to increase exposure to core inpatient and transition of care concepts. The remainder of the experiences are longitudinal and a mix of core and elective.  The length of electives vary, therefore a resident’s number of electives can also vary.  Residents typically spend 5-6 half days weekly in direct patient care.  Rotation selections will be guided by the Residency Program Director, and will ensure that the resident achieves a broad range of experiences and exposure to various patient populations.

Other key experiences during the residency will include the completion of a major research project, the completion of a quality improvement project, completion of an administrative ambulatory project, participation in a resident research series, delivery of 6 informal noon conferences and 1 formal educational lecture, and development or expansion of clinical pharmacy services.   The resident will also have the opportunity to attend the ASHP Midyear Clinical Meeting in addition to presenting their finalized research project at a Pharmacy Residency Conference.

Core Rotations

  • Orientation (1 month)
  • Acute care cardiology (1 month; encouraged, not required)
  • Primary Care/Population Health at COPC (10 months)
  • Anticoagulation Management Service (10 months)
  • Ambulatory Pharmacy Administration (10 months)
  • Lipid Management/Cardiovascular Risk Reduction Service (6 months)
  • Anti-arrhythmic Medication Monitoring (2-3 months)
  • Smoking Cessation Clinic (2-3 months)
  • Heart Failure (2-3 months)
  • Bone Health (2-3 months)
  • Subspecialties (2-3 months)

Core Subspecialty Rotations

  • Endocrinology (Diabetes)
  • Neurology (Multiple Sclerosis, Neuromuscular, Headache)
  • Nephrology
  • Inflammatory Bowel Disease
  • Rheumatology

Elective Rotations

  • Outpatient Electrophysiology
  • Infectious Disease (HIV/PrEP)
  • Pediatrics
  • Sickle Cell Disease
  • Transitions of Care (Cardiology, Diabetes)
  • Family Medicine AT OSUWMC
  • Medication Assistance
  • Medication Therapy Management
  • Emergency Medicine
  • Hemophilia Management
  • Hepatitis C Management
  • Perioperative Pharmacy Management (OPAC)
  • Pain and Palliative
  • Oncology
  • Solid Organ Transplant

Key Preceptors

Aaron Bagnola, PharmD, BCPS, BCCP

Kelly Bartsch, PharmD, BCPS, CLS

Erica Davidson, PharmD, ACE, BCACP, CLS

Paige Erdeljac, PharmD, MPH, BCACP

Margaret Hansen, PharmD

Margie Hevezi, PharmD, CDE, CLS

Sarah Hill, PharmD, BCPS

Ariel Holland, PharmD BCACP

Adam Ingram, PharmD, BCACP

Amy James, PharmD, BCACP, CACP, BC-ADM

Allison McFerran, PharmD

Natalie Nielson, PharmD, AAHIVP, BCACP

Tiffany Ortman, PharmD, BCACP, CACP

Caitlin Parks, PharmD, BCACP

Maggie Ragger, PharmD, BCACP, CDCES

Hannah Rhinehart, PharmD, BCACP

Alyssa Rinaldi, PharmD, BCACP

Kim Simon, PharmD, BCPS

Diana Venci, PharmD, BCPS, BCGP, CLS

Stephanie Yager, PharmD, BCACP

Selected Resident Research

  • Experience With Pre-Procedural Hemostatic Medications versus Platelet Transfusion in Patients with Platelet Storage Pool Deficiency. Lundy KA, Rabatin A, Davidson ER, Li J, Snider MJ, Kraut EH.J Pharm Pract. 2023 Dec;36(6):1412-1418. doi: 10.1177/08971900221119167. Epub 2022 Aug 17.
  • The Impact of a Diabetes Transitions of Care Clinic on Hospital Utilization and Patient Care. Rinaldi A, Snider M, James A, Harris C, Cephas Hill K, Li J, Wyne K. Ann Pharmacother. 2023 Feb;57(2):127-132. doi: 10.1177/10600280221102557. Epub 2022 Jun 9.
  • Risk Versus Benefit of Combined Aspirin and Warfarin Therapy in Patients with Atrial Fibrillation. Nagaraj TA, Snider MJ, Davidson E, Weiss R, Li J, Afzal M.J Pharm Pract. 2021 Oct;34(5):766-773. doi: 10.1177/0897190020916638. Epub 2020 Apr 15.
  • Trends in Anticoagulation Management Services Following Incorporation of Direct Oral Anticoagulants at a Large Academic Medical Center. Mills C, Snider MJ, Ortman TC, Dush A, Hevezi MS, Li J, Weiss R, Kraut E. J Thromb Thrombolysis. 2021 May;51(4):1050-1058. doi: 10.1007/s11239-020-02286-2. Epub 2020 Oct 9.
  • Tolerance of Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) Inhibitors in Patients with Self-Reported Statin Intolerance. Davidson ER, Snider MJ, Bartsch K, Hirsch A, Li J, Larry J. J Pharm Pract. 2020 Jun;33(3):276-282. doi: 10.1177/0897190018799218. Epub 2018 Sep 16.

Benefits and Additional Requirements

Application Deadline:  January 6

We welcome applications from non-U.S. citizens who have a “green card” (permanent resident status) or a current visa valid through the entire duration of the residency program. The Ohio State University pharmacy residency programs are NOT able to sponsor visas for pharmacy residents (PGY1 or PGY2).


Positions: 3

Start Date: July 1

Annual Salary – $54,000

Vacation Days – 10 days

Staffing Requirement – 17 weekends per year

Completion of a Major Research Project


Download PDF